3SGMO : 8 Analysts Assess Sangamo Therapeutics: What You Need To Know
In the assessment of 12-month price targets, analysts unveil insights for Sangamo Therapeutics, presenting an average target ...
US Futures Show Caution Among Investors Ahead Of FOMC Meeting: Analysts Say Only Certainty Is That 'Things Will Remain Uncertain For The Time Being'
U.S. stock futures were flat on Tuesday after a bounce back on Monday. Futures of all four benchmark indices were mixed in premarket trading.
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 17, 2025 Sangamo Therapeutics, Inc. misses on earnings expectations. Reported EPS is $ ...
Q4 2024 Sangamo Therapeutics Inc Earnings Call
Alexander Macrae; President, Chief Executive Officer, Director; Sangamo Therapeutics Inc Nathalie Dubois- Stringfellow; Senior Vice President, Chief Development Officer; Sangamo Therapeutics Inc Good ...
RBC Capital Sticks to Their Hold Rating for Sangamo Biosciences (SGMO)
In a report released yesterday, Luca Issi from RBC Capital maintained a Hold rating on Sangamo Biosciences (SGMO – Research Report), with a ...
Sangamo Biosciences (SGMO) Gets a Hold from Wells Fargo
In a report released today, Yanan Zhu from Wells Fargo maintained a Hold rating on Sangamo Biosciences (SGMO – Research Report), with a price ...
Barron's12h
Barron’s Stock Picks
Here is how the Barron’s Roundtable members’ picks performed. Find investment ideas for your portfolio with the latest stock picks from Barron’s below. These picks are the product of the ...
moneycontrol.com14h
US Markets
Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...